#PCORI2018
Decision Making in Advanced Heart Failure
Larry A. Allen, MD, MHS Ginny Meadows, MSHI, RN-BC
Professor, University of Colorado School of Medicine Caregiver
Decision Making in Advanced Heart Failure Larry A. Allen, MD, MHS - - PowerPoint PPT Presentation
Decision Making in Advanced Heart Failure Larry A. Allen, MD, MHS Ginny Meadows, MSHI, RN-BC Professor, University of Colorado School of Medicine Caregiver #PCORI2018 Larry Allen, MD, MHS Disclosures Rela latio ionship ip Company ny(ies
#PCORI2018
Larry A. Allen, MD, MHS Ginny Meadows, MSHI, RN-BC
Professor, University of Colorado School of Medicine Caregiver
2 • November 15, 2018
Rela latio ionship ip Company ny(ies es) Speakers Bureau Advisory Committee Consultancy ACI Clinical, Amgen/Cytokinetics, Boston Scientific, Janssen Review Panel Board Membership Honorarium Ownership Interests blank blank blank blank blank blank
3 • November 15, 2018
4 • November 15, 2018
5 • November 15, 2018
6 • November 15, 2018
7 • November 15, 2018
McIlvennan, Magid, Ambardekar, Thompson, Matlock, Allen. Circ Heart Fail. 2014
8 • November 15, 2018
9 • November 15, 2018
Content analysis of 77 LVAD educational materials
Iacovetto et al. Circ Qual Care Outcomes. 2014.
10 • November 15, 2018
11 • November 15, 2018
McIlvennan et al. Circ Qual Care Outcomes. 2014.
12 • November 15, 2018
13 • November 15, 2018
Thompson et al. JACC-HF. 2016.
14 • November 15, 2018
McIvennan et al. J Cardiovasc Nurs. 2016.
15 • November 15, 2018
McIvennan et al. J Cardiovasc Nurs. 2016.
16 • November 15, 2018
blank Control (n=135) Intervention (n=113) Age, mean years (SD) 63.5 (9.7) 63.2 (10.2) Male 82.2% 86.7% White, non-Hispanic 79.1% 82.7% Some college or more 56.4% 69.2% On Disability 27.6% 32.0% Married 72.5% 65.4% Diagnosed < 2 years 11.9% 12.4% Enrolled in ICU 21.5% 26.5% INTERMACS 4-7 (p<0.01) 18.3% 44.6%
Allen et al. JAMA-IM. 2018.
17 • November 15, 2018
Allen et al. JAMA-IM. 2018.
18 • November 15, 2018
Allen et al. JAMA-IM. 2018.
19 • November 15, 2018
26% decrease in patient going
Patients avoid aggressive therapy inconsistent with their goals at end-of-life Limit use of a $300,000 treatment Scare people out of life-saving therapy Undermine lucrative services offered by well-meaning programs
Allen et al. JAMA-IM. 2018.
80% 54%
20 • November 15, 2018
21 • November 15, 2018
22 • November 15, 2018